Published 2 hours ago • loading... • Updated 2 hours ago

Promising Healthcare Stocks To Follow Today - September 29th

Moderna, Eli Lilly and Company, Iovance Biotherapeutics, Medtronic, and Amgen are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in medical services, pharmaceuticals, biotechnology, medical

1 Articles

MarketBeat

Center

Promising Healthcare Stocks To Follow Today - September 29th

2 hours ago·Sioux Falls, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated1 hour agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States 2 hours ago on Tuesday, September 29, 2026.

Sources are mostly out of (0)

Promising Healthcare Stocks To Follow Today - September 29th

1 Articles

1 Articles

Promising Healthcare Stocks To Follow Today - September 29th

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Novo Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Lilly’s Mounjaro

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a ...

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

From habit to health: New paths forward for veterans who smoke

Fed’s Williams sees no urgency for next Fed rate hike

The Scoop: Eli Lilly Defends Presence at Vogue World

Similar News Topics

Similar News Topics

More stories like this

Novo Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Lilly’s Mounjaro

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a ...

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

From habit to health: New paths forward for veterans who smoke

Fed’s Williams sees no urgency for next Fed rate hike

The Scoop: Eli Lilly Defends Presence at Vogue World

Promising Healthcare Stocks To Follow Today - September 29th

1 Articles

1 Articles

Promising Healthcare Stocks To Follow Today - September 29th

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Novo Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Lilly’s Mounjaro

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a ...

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

From habit to health: New paths forward for veterans who smoke

Fed’s Williams sees no urgency for next Fed rate hike

The Scoop: Eli Lilly Defends Presence at Vogue World

Similar News Topics

Similar News Topics

More stories like this

Novo Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Lilly’s Mounjaro

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a ...

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

From habit to health: New paths forward for veterans who smoke

Fed’s Williams sees no urgency for next Fed rate hike

The Scoop: Eli Lilly Defends Presence at Vogue World

Bias Distribution

Factuality